| 000 | 01554 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250517061640.0 | ||
| 264 | 0 | _c20160209 | |
| 008 | 201602s 0 0 eng d | ||
| 022 | _a1879-3592 | ||
| 024 | 7 |
_a10.1016/j.mrgentox.2015.06.006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMosesso, P | |
| 245 | 0 | 0 |
_aCytogenetic evidence that DNA topoisomerase II is not involved in radiation induced chromsome-type aberrations. _h[electronic resource] |
| 260 |
_bMutation research. Genetic toxicology and environmental mutagenesis _cNov 2015 |
||
| 300 |
_a14-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aChromosome Aberrations _xdrug effects |
| 650 | 0 | 4 |
_aChromosomes, Human _xdrug effects |
| 650 | 0 | 4 | _aCytogenetic Analysis |
| 650 | 0 | 4 |
_aDNA End-Joining Repair _xdrug effects |
| 650 | 0 | 4 |
_aDNA Topoisomerases, Type II _xmetabolism |
| 650 | 0 | 4 |
_aDexrazoxane _xpharmacology |
| 650 | 0 | 4 |
_aEtoposide _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphocytes _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aResting Phase, Cell Cycle _xdrug effects |
| 650 | 0 | 4 |
_aTopoisomerase II Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aX-Rays |
| 700 | 1 | _aPepe, G | |
| 700 | 1 | _aOttavianelli, A | |
| 700 | 1 | _aSchinoppi, A | |
| 700 | 1 | _aCinelli, S | |
| 773 | 0 |
_tMutation research. Genetic toxicology and environmental mutagenesis _gvol. 793 _gp. 14-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.mrgentox.2015.06.006 _zAvailable from publisher's website |
| 999 |
_c25405619 _d25405619 |
||